Tirzepatide vs Ublituximab

## Tirzepatide vs Ublituximab: Overview

This comparison examines the pharmacological differences between **Tirzepatide** and **Ublituximab**.

## Mechanism of Action

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Tirzepatide — 5 days; Ublituximab — N/A.

## Chemical Properties

**Type**: Tirzepatide — Protein; Ublituximab — Antibody.